A Retrospective Study of COVID-19 Treatments

ProgenaBiome

Status: Completed

Conditions: COVID-19 Respiratory Infection; COVID-19 Pneumonia; COVID-19 Acute Respiratory Distress Syndrome; SARS-CoV2 Infection; COVID-19 Lower Respiratory Infection; Covid19; COVID-19 Acute Bronchitis; SARS-CoV-2 Acute Respiratory Disease

Treatments: Other: No Intervention Used

Study type: Observational

Funder types: Other

Identifiers

NCT04949230

PRG-051

Details and patient eligibility

About

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Full description

Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.

Enrollment: 300 patients

Sex: All

Ages: 18+ months old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
2. Male or female of 18 years of age or older
3. Diagnosis of COVID-19 infection by RT- PCR
4. Recovery from COVID-19

Exclusion Criteria:

Trial design

300 participants in 1 patient group

COVID-19 Patients

Description:

Subjects who have recovered from COVID-19

Treatment:

Other: No Intervention Used